Prospective Cohort Study on Fuzheng Yangxin Prescription For Rapid Rehabilitation of Patients With Qi-Yin Deficiency Syndrome After Coronary Artery Bypass Grafting

RecruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

June 30, 2026

Conditions

Coronary Artery Bypass

Interventions

DRUG

Fuzheng Yangxin prescription

DRUG

placebo

Trial Locations (1)

RECRUITING

Peking university third hospital, Beijing

All Listed Sponsors

lead

Peking University Third Hospital

OTHER